PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
PVRI GoDeep
PVRI Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
1 other identifier
observational
40,000
1 country
1
Brief Summary
PVRI-GoDeep is a PH Meta-Registry, run under the umbrella of the Pulmonary Vascular Research Institute (PVRI). It merges anonymized PH patient related data from various local registries around the world run under the responsibility of PVRI members. It will be operated under the auspices of the University of Giessen/Giessen PH center. Combining deep phenotyping with worldwide outreach, PVRI-GoDeep aims to offer insights into specific geographical and ethnical profiles of PH, to deepen the epidemiological, clinical and molecular understanding of this disease and to promote strategies for improved individualized treatment of PH patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2020
CompletedFirst Submitted
Initial submission to the registry
March 14, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2055
April 4, 2025
April 1, 2025
30 years
March 14, 2022
April 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global analysis of PH patients
Global comparison and analysis of the course of disease of PH patients
From entry into the registry up to 10 years
Study Arms (2)
Patients with Pulmonary Hypertension
Patients with a diagnosis of pulmonary hypertension typically diagnosed via right heart catheterization.
Control Group
Participating PH centers can optionally provide data about patients with exclusion of pulmonary hypertension
Eligibility Criteria
Global cohort of patients with pulmonary hypertension (PH)
You may qualify if:
- Clinical Diagnosis of Pulmonary Hypertension
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Giessenlead
- Imperial College Londoncollaborator
- Johns Hopkins Universitycollaborator
- Stanford Universitycollaborator
- University of Sheffieldcollaborator
- University of Pittsburghcollaborator
- University of Paviacollaborator
- Hospital de Niños de la Santísima Trinidadcollaborator
- Academy of Medical Sciences of Ukrainecollaborator
- The Methodist Hospital Research Institutecollaborator
- Vanderbilt University Medical Centercollaborator
- Mayo Cliniccollaborator
- National and Kapodistrian University of Athenscollaborator
- Aristotle University Of Thessalonikicollaborator
- University Hospital of Targu Mures, Romaniacollaborator
- University Hospital Heidelbergcollaborator
- Milpark Hospitalcollaborator
- University of Minnesotacollaborator
- Royal Prince Alfred Hospital, Sydney, Australiacollaborator
- Fiona Stanley Hospitalcollaborator
- Sunshine Coast University Hospitalcollaborator
- China-Japan Friendship Hospitalcollaborator
- Medical University of Grazcollaborator
- National Hospital Organization Okayama Medical Centercollaborator
- Royal Hobart Hospitalcollaborator
- University Hospital, Zürichcollaborator
- Universidad Nacional de La Platacollaborator
- Gold Coast Hospital and Health Servicecollaborator
Study Sites (1)
University Giessen PH Center
Giessen, Hesse, 35392, Germany
Related Publications (1)
Yogeswaran A, Gall H, Funderich M, Wilkins MR, Howard L, Kiely DG, Lawrie A, Hassoun PM, Sirenklo Y, Torbas O, Sweatt AJ, Zamanian RT, Williams PG, Frauendorf M, Arvanitaki A, Giannakoulas G, Saleh K, Sabbour H, Cajigas HR, Frantz R, Al Ghouleh I, Chan SY, Brittain E, Annis JS, Pepe A, Ghio S, Orfanos S, Anthi A, Majeed RW, Wilhelm J, Ghofrani HA, Richter MJ, Grimminger F, Sahay S, Tello K, Seeger W; Pulmonary Vascular Research Institute GoDeep Consortium. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis. Chest. 2024 Sep;166(3):585-603. doi: 10.1016/j.chest.2024.03.018. Epub 2024 Mar 19.
PMID: 38508334DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2022
First Posted
April 15, 2022
Study Start
January 30, 2020
Primary Completion (Estimated)
January 30, 2050
Study Completion (Estimated)
January 30, 2055
Last Updated
April 4, 2025
Record last verified: 2025-04